Cargando…

SARS-CoV-2 (COVID-19) pneumonia patient treated with two doses of infliximab within 2 weeks for acute severe ulcerative colitis: A case report

RATIONALE: The ongoing coronavirus pandemic has caused severe acute respiratory syndrome, posing a significant challenge for patients receiving immunotherapy for immune-mediated inflammatory diseases. As of January 2022, immunosuppressants such as tumor necrosis factor inhibitors (anti-TNFα) and aza...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alhalabi, Marouf, Eddin, Kamal Alaa, Ali, Fadwa, Abbas, Ahmad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	4500
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797526/ https://www.ncbi.nlm.nih.gov/pubmed/35089243 http://dx.doi.org/10.1097/MD.0000000000028722

Ejemplares similares

Subcutaneous golimumab induced and maintained clinical response in a child with a biological-experienced steroid-refractory flare of ulcerative colitis: A case report
por: Alhalabi, Marouf, et al.
Publicado: (2021)

Mortality and risk factors associated with peptic ulcer bleeding among adult inpatients of Damascus Hospital, Syria: A cross-sectional study
por: Alhalabi, Marouf Mouhammad
Publicado: (2023)

Sarcoidosis associated with infliximab therapy in ulcerative colitis: A case report
por: Gîlcă, Georgiana-Emmanuela, et al.
Publicado: (2017)

Efficacy of infliximab, cyclosporine and tacrolimus on ulcerative colitis: A meta-analysis
por: Jia, Xuemei, et al.
Publicado: (2020)

Network meta-analysis and cost-effectiveness analysis of infliximab, cyclosporine and tacrolimus for ulcerative colitis
por: Wang, Xueqi, et al.
Publicado: (2022)

Ustekinumab for steroid-refractory pancolitis in a biologically naive child: A case report and literature review
por: Alhalabi, Marouf
Publicado: (2023)

Ulcerative colitis-associated bronchiectasis: A rare extraintestinal manifestation of inflammatory bowel disease: A case report
por: Alhalabi, Marouf, et al.
Publicado: (2022)

Prospective comparison of preference and efficacy of adalimumab and infliximab for treating ulcerative colitis naive to antitumor necrosis factor therapy
por: Mizoshita, Tsutomu, et al.
Publicado: (2017)

Optimizing individualized management of patients with ulcerative colitis: Identification of risk factors predicting ulcerative colitis-associated neoplasia
por: Jiang, Wenyu, et al.
Publicado: (2023)

Subcutaneous golimumab to treat a biological naïve chronically active ulcerative colitis child. A case report
por: Alhalabi, Marouf M., et al.
Publicado: (2022)

Efficacy of two-week therapy with doxycycline-based quadruple regimen versus levofloxacin concomitant regimen for helicobacter pylori infection: a prospective single-center randomized controlled trial
por: Alhalabi, Marouf, et al.
Publicado: (2021)

The ulcerative colitis endoscopic index of severity score is superior to reflecting long-term prognosis in ulcerative colitis patients treated with vedolizumab
por: Yan, Jing, et al.
Publicado: (2023)

Endoscopy within 7 days after detecting high calprotectin levels can be useful for therapeutic decision-making in ulcerative colitis
por: Yong, Ho Min, et al.
Publicado: (2021)

Endocytoscopic classification can be predictive for relapse in ulcerative colitis
por: Ueda, Naoki, et al.
Publicado: (2018)

Ulcerative colitis and thrombocytosis: Case report and literature review
por: Zhou, Yaqi, et al.
Publicado: (2023)

Meta-analysis and trial sequential analysis of acupoint catgut embedding in the treatment of ulcerative colitis: Acupoint catgut embedding treating ulcerative colitis meta-analysis
por: Yu, Yunfeng, et al.
Publicado: (2022)

Lymphocyte infiltration and key differentially expressed genes in the ulcerative colitis
por: Zhang, Junhui, et al.
Publicado: (2020)

Pathological mechanism and targeted drugs of ulcerative colitis: A review
por: Guo, Meitong, et al.
Publicado: (2023)

Gallstone prevalence and risk factors in patients with ulcerative colitis in Korean population
por: Jeong, Yo Han, et al.
Publicado: (2017)

Ulcerative colitis with acute pleurisy: A case report and review of the literature
por: Lu, Shuming, et al.
Publicado: (2017)

Fecal microbiota transplantation is a rescue treatment modality for refractory ulcerative colitis
por: Uygun, Ahmet, et al.
Publicado: (2017)

Features of the gut microbiota in ulcerative colitis patients with depression: A pilot study
por: Chen, De-Liang, et al.
Publicado: (2021)

Ustekinumab is effective against ulcerative colitis with intestinal stenosis: A case report
por: Liu, Ailing, et al.
Publicado: (2022)

Infliximab in ulcerative colitis
por: Levin, Avi, et al.
Publicado: (2008)

Beverage consumption and risk of ulcerative colitis: Systematic review and meta-analysis of epidemiological studies
por: Nie, Jia-Yan, et al.
Publicado: (2017)

Ulcerative colitis followed by the development of typical intestinal Behçet disease: A case report
por: Zhu, Zhenhua, et al.
Publicado: (2018)

Risk factors for ulcerative colitis-associated colorectal cancer: A retrospective cohort study
por: de Campos Silva, Elen Farinelli, et al.
Publicado: (2020)

Intestinal flora differences between patients with ulcerative colitis of different ethnic groups in China
por: Liu, Huan, et al.
Publicado: (2021)

Fecal calprotectin as a noninvasive test to predict deep remission in patients with ulcerative colitis
por: Malvão, Ludimilla dos Reis, et al.
Publicado: (2021)

Evaluation of the relationship between the spleen volume and the disease activity in ulcerative colitis and Crohn disease
por: Kawashima, Kazumasa, et al.
Publicado: (2022)

Sustained effect of leukocytapheresis/granulocytapheresis versus anti-human TNF-α monoclonal antibody on ulcerative colitis: A 2-year retrospective study
por: Sakai, Masahiro, et al.
Publicado: (2023)

Cerebral venous sinus thrombosis in a young patient with ulcerative colitis: A case report
por: Deskur, Anna, et al.
Publicado: (2019)

Clinical implications of fecal calprotectin and fecal immunochemical test on mucosal status in patients with ulcerative colitis
por: Ryu, Dae Gon, et al.
Publicado: (2019)

Identification of 6 cuproptosis-related genes for active ulcerative colitis with both diagnostic and therapeutic values
por: Zou, Menglong, et al.
Publicado: (2023)

Fecal Microbiota Transplantation as a Novel Therapy for Ulcerative Colitis: A Systematic Review and Meta-Analysis
por: Sun, Dali, et al.
Publicado: (2016)

Huang Lian for ulcerative colitis: A protocol of systematic review and meta-analysis of randomized clinical trials
por: Li, Tinglin, et al.
Publicado: (2020)

Japanese pediatric patient with moderately active ulcerative colitis successfully treated with ustekinumab: A case report
por: Kakiuchi, Toshihiko, et al.
Publicado: (2022)

Comparative study between histochemical mucus volume, histopathological findings, and endocytoscopic scores in patients with ulcerative colitis
por: Kamitani, Yu, et al.
Publicado: (2023)

Quality of Life Is Related to Fecal Calprotectin Concentrations in Colonic Crohn Disease and Ulcerative Colitis, but not in Ileal Crohn Disease
por: Gauss, Annika, et al.
Publicado: (2016)

Efficacy and safety evaluation of acupoint embedding for patients with ulcerative colitis: A protocol of systematic review and meta-analysis
por: Lu, Jinhua, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_na4otim73and6e07l9jss9o30m